Skip to main content

Table 2 Summary of selected features of BRCA1 carriers diagnosed with cancer during the follow-up period

From: Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy

Type and number

Peritoneal cancer

n = 2

Primary breast cancer

n = 6

Contralateral breast cancer

n = 3

Breast cancer recurrence

n = 5

Total for the whole group diagnosed with cancers

n = 16

Feature and type of mutation

Patient age at the time of cancer diagnosis (mean; years old)

60

50.00

58.67

51.00

53.19

Time from RRSO to cancer diagnosis (mean; months)

46

53

58.67

25.4

44,56

Type of BRCA1 mutation in patients who developed cancer during follow-up period

2x c.181T > G

4x c.5266dupC 1x c.181T > G 1x c.4035delA

2x c.5266dupC 1x c.181T > G

5x c.5266dupC

11x c.5266dupC 4x c.181T > G 1x c.4035delA